Lucas Ward
Stock Analyst at Ascendiant Capital
(0.25)
# 4,107
Out of 4,829 analysts
15
Total ratings
20%
Success rate
-45.2%
Average return
Main Sectors:
Stocks Rated by Lucas Ward
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VVOS Vivos Therapeutics | Maintains: Buy | $6.6 → $6.2 | $3.00 | +106.67% | 3 | Apr 15, 2025 | |
| LIQT LiqTech International | Reiterates: Buy | $3.2 → $3.4 | $1.42 | +139.44% | 4 | Apr 7, 2025 | |
| HSCS HeartSciences | Maintains: Buy | $15 → $14 | $3.43 | +308.33% | 2 | Mar 18, 2025 | |
| ACON Aclarion | Maintains: Buy | $555 → $481 | $7.10 | +6,674.65% | 3 | Nov 27, 2024 | |
| VMAR Vision Marine Technologies | Maintains: Buy | $3,375 → $2,700 | $6.71 | +40,164.25% | 2 | Jul 29, 2024 | |
| SXTP 60 Degrees Pharmaceuticals | Initiates: Buy | $144 | $2.39 | +5,925.10% | 1 | Oct 2, 2023 |
Vivos Therapeutics
Apr 15, 2025
Maintains: Buy
Price Target: $6.6 → $6.2
Current: $3.00
Upside: +106.67%
LiqTech International
Apr 7, 2025
Reiterates: Buy
Price Target: $3.2 → $3.4
Current: $1.42
Upside: +139.44%
HeartSciences
Mar 18, 2025
Maintains: Buy
Price Target: $15 → $14
Current: $3.43
Upside: +308.33%
Aclarion
Nov 27, 2024
Maintains: Buy
Price Target: $555 → $481
Current: $7.10
Upside: +6,674.65%
Vision Marine Technologies
Jul 29, 2024
Maintains: Buy
Price Target: $3,375 → $2,700
Current: $6.71
Upside: +40,164.25%
60 Degrees Pharmaceuticals
Oct 2, 2023
Initiates: Buy
Price Target: $144
Current: $2.39
Upside: +5,925.10%